

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 6.84441034 |
| 2 | muscle filament sliding (GO:0030049) | 6.27287159 |
| 3 | actin-myosin filament sliding (GO:0033275) | 6.27287159 |
| 4 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.85216557 |
| 5 | myofibril assembly (GO:0030239) | 5.84075971 |
| 6 | regulation of skeletal muscle contraction (GO:0014819) | 5.75787531 |
| 7 | cardiac myofibril assembly (GO:0055003) | 5.66053278 |
| 8 | regulation of plasminogen activation (GO:0010755) | 5.59845355 |
| 9 | homocysteine metabolic process (GO:0050667) | 5.55809936 |
| 10 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.46106845 |
| 11 | tricarboxylic acid cycle (GO:0006099) | 5.46025768 |
| 12 | heme biosynthetic process (GO:0006783) | 5.43599605 |
| 13 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.30451512 |
| 14 | protoporphyrinogen IX metabolic process (GO:0046501) | 5.29891126 |
| 15 | porphyrin-containing compound biosynthetic process (GO:0006779) | 5.23515637 |
| 16 | regulation of relaxation of muscle (GO:1901077) | 5.18806109 |
| 17 | polyketide metabolic process (GO:0030638) | 5.17135225 |
| 18 | doxorubicin metabolic process (GO:0044598) | 5.17135225 |
| 19 | daunorubicin metabolic process (GO:0044597) | 5.17135225 |
| 20 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 5.10790110 |
| 21 | actin-mediated cell contraction (GO:0070252) | 5.01058086 |
| 22 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.93977760 |
| 23 | heart process (GO:0003015) | 4.93644681 |
| 24 | heart contraction (GO:0060047) | 4.93644681 |
| 25 | desmosome organization (GO:0002934) | 4.92608557 |
| 26 | cardiac muscle contraction (GO:0060048) | 4.91567948 |
| 27 | tetrapyrrole biosynthetic process (GO:0033014) | 4.87916205 |
| 28 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.80460592 |
| 29 | regulation of cell communication by electrical coupling (GO:0010649) | 4.58420757 |
| 30 | synaptic vesicle maturation (GO:0016188) | 4.53358151 |
| 31 | plasma membrane repair (GO:0001778) | 4.46045099 |
| 32 | negative regulation of catenin import into nucleus (GO:0035414) | 4.43753889 |
| 33 | regulation of actin filament-based movement (GO:1903115) | 4.40592973 |
| 34 | glutamate secretion (GO:0014047) | 4.39420560 |
| 35 | oxidative phosphorylation (GO:0006119) | 4.38434628 |
| 36 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.35738891 |
| 37 | striated muscle contraction (GO:0006941) | 4.34509795 |
| 38 | heme metabolic process (GO:0042168) | 4.34021379 |
| 39 | skeletal muscle adaptation (GO:0043501) | 4.32034832 |
| 40 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.24347908 |
| 41 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.23341724 |
| 42 | cardiac muscle cell development (GO:0055013) | 4.20908927 |
| 43 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.11726955 |
| 44 | microtubule nucleation (GO:0007020) | 4.10364457 |
| 45 | sulfur amino acid catabolic process (GO:0000098) | 4.08887102 |
| 46 | oxygen transport (GO:0015671) | 4.07081742 |
| 47 | porphyrin-containing compound metabolic process (GO:0006778) | 4.04644346 |
| 48 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.01949143 |
| 49 | actomyosin structure organization (GO:0031032) | 3.95850340 |
| 50 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.94357124 |
| 51 | gas transport (GO:0015669) | 3.89341300 |
| 52 | skeletal muscle contraction (GO:0003009) | 3.88493618 |
| 53 | cardiac cell development (GO:0055006) | 3.87088271 |
| 54 | protein-chromophore linkage (GO:0018298) | 3.86801654 |
| 55 | synaptic vesicle exocytosis (GO:0016079) | 3.85468043 |
| 56 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.79611157 |
| 57 | cellular response to zinc ion (GO:0071294) | 3.79521274 |
| 58 | regulation of striated muscle contraction (GO:0006942) | 3.78689394 |
| 59 | galactose metabolic process (GO:0006012) | 3.77781354 |
| 60 | carnitine shuttle (GO:0006853) | 3.76375156 |
| 61 | quinone biosynthetic process (GO:1901663) | 3.74799777 |
| 62 | ubiquinone biosynthetic process (GO:0006744) | 3.74799777 |
| 63 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.71328978 |
| 64 | regulation of sarcomere organization (GO:0060297) | 3.68687646 |
| 65 | galactose catabolic process (GO:0019388) | 3.67343254 |
| 66 | cochlea development (GO:0090102) | 3.66313902 |
| 67 | white fat cell differentiation (GO:0050872) | 3.65971332 |
| 68 | NADH metabolic process (GO:0006734) | 3.64722696 |
| 69 | creatine metabolic process (GO:0006600) | 3.63740829 |
| 70 | innervation (GO:0060384) | 3.62232001 |
| 71 | striated muscle atrophy (GO:0014891) | 3.58808853 |
| 72 | cysteine metabolic process (GO:0006534) | 3.57362169 |
| 73 | cardiac muscle hypertrophy (GO:0003300) | 3.56112146 |
| 74 | respiratory electron transport chain (GO:0022904) | 3.54610602 |
| 75 | actin filament-based movement (GO:0030048) | 3.54522992 |
| 76 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.51037788 |
| 77 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.50768827 |
| 78 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.48073184 |
| 79 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.47861727 |
| 80 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.46251982 |
| 81 | electron transport chain (GO:0022900) | 3.45951652 |
| 82 | oxaloacetate metabolic process (GO:0006107) | 3.45095139 |
| 83 | ATP synthesis coupled proton transport (GO:0015986) | 3.44847383 |
| 84 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.44847383 |
| 85 | striated muscle hypertrophy (GO:0014897) | 3.43589157 |
| 86 | negative regulation of cell size (GO:0045792) | 3.40540886 |
| 87 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.39680467 |
| 88 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.37722759 |
| 89 | primary amino compound metabolic process (GO:1901160) | 3.36858508 |
| 90 | carnitine transmembrane transport (GO:1902603) | 3.31596264 |
| 91 | regulation of cofactor metabolic process (GO:0051193) | 3.31125326 |
| 92 | regulation of coenzyme metabolic process (GO:0051196) | 3.31125326 |
| 93 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.30415652 |
| 94 | protein retention in ER lumen (GO:0006621) | 3.27672151 |
| 95 | response to parathyroid hormone (GO:0071107) | 3.27485098 |
| 96 | peptidyl-proline hydroxylation (GO:0019511) | 3.26693235 |
| 97 | muscle atrophy (GO:0014889) | 3.25283028 |
| 98 | inner ear receptor cell development (GO:0060119) | 3.24895546 |
| 99 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.24425612 |
| 100 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.24425612 |
| 101 | erythrocyte maturation (GO:0043249) | 3.22625453 |
| 102 | phosphatidylglycerol biosynthetic process (GO:0006655) | 3.21417695 |
| 103 | muscle hypertrophy (GO:0014896) | 3.20676310 |
| 104 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.18045424 |
| 105 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.17629565 |
| 106 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.17424412 |
| 107 | cell migration involved in heart development (GO:0060973) | 3.17286196 |
| 108 | erythrocyte development (GO:0048821) | 3.16814907 |
| 109 | positive regulation of synapse maturation (GO:0090129) | 3.16683434 |
| 110 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.15207171 |
| 111 | purine nucleotide salvage (GO:0032261) | 3.14912586 |
| 112 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.14589551 |
| 113 | 2-oxoglutarate metabolic process (GO:0006103) | 3.13823774 |
| 114 | locomotory exploration behavior (GO:0035641) | 3.13708613 |
| 115 | striated muscle adaptation (GO:0014888) | 3.11346206 |
| 116 | regulation of ATP catabolic process (GO:1903289) | 3.10815115 |
| 117 | regulation of ATPase activity (GO:0043462) | 3.10815115 |
| 118 | cellular potassium ion homeostasis (GO:0030007) | 3.10675729 |
| 119 | adult heart development (GO:0007512) | 3.10647610 |
| 120 | ubiquinone metabolic process (GO:0006743) | 3.10431449 |
| 121 | fatty acid transmembrane transport (GO:1902001) | 3.08968324 |
| 122 | 4-hydroxyproline metabolic process (GO:0019471) | 3.08924414 |
| 123 | postsynaptic membrane organization (GO:0001941) | 3.07163609 |
| 124 | neuronal ion channel clustering (GO:0045161) | 3.06785388 |
| 125 | sodium ion export (GO:0071436) | 3.05273823 |
| 126 | response to inactivity (GO:0014854) | 3.04498723 |
| 127 | regulation of sequestering of triglyceride (GO:0010889) | 3.03331926 |
| 128 | cerebellar granule cell differentiation (GO:0021707) | 3.02452585 |
| 129 | behavioral defense response (GO:0002209) | 3.02344142 |
| 130 | behavioral fear response (GO:0001662) | 3.02344142 |
| 131 | neurotransmitter secretion (GO:0007269) | 3.01912020 |
| 132 | positive regulation of cation channel activity (GO:2001259) | 3.00971339 |
| 133 | response to muscle activity (GO:0014850) | 2.99833144 |
| 134 | exploration behavior (GO:0035640) | 2.98826694 |
| 135 | aerobic respiration (GO:0009060) | 2.97166265 |
| 136 | tricarboxylic acid metabolic process (GO:0072350) | 2.94999263 |
| 137 | regulation of cardiac muscle contraction (GO:0055117) | 2.94903117 |
| 138 | amino-acid betaine transport (GO:0015838) | 2.94690892 |
| 139 | carnitine transport (GO:0015879) | 2.94690892 |
| 140 | regulation of tight junction assembly (GO:2000810) | 2.94478148 |
| 141 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.93811694 |
| 142 | muscle tissue morphogenesis (GO:0060415) | 2.91997108 |
| 143 | muscle contraction (GO:0006936) | 2.91334566 |
| 144 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.89493198 |
| 145 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 2.89285112 |
| 146 | succinate metabolic process (GO:0006105) | 2.87390042 |
| 147 | glycogen catabolic process (GO:0005980) | 2.86880351 |
| 148 | heart trabecula formation (GO:0060347) | 2.86733973 |
| 149 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.86142121 |
| 150 | COPII vesicle coating (GO:0048208) | 2.84934058 |
| 151 | regulation of female receptivity (GO:0045924) | 2.83613065 |
| 152 | neuronal action potential propagation (GO:0019227) | 2.82320263 |
| 153 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.80198323 |
| 154 | negative regulation of Ras GTPase activity (GO:0034261) | 2.78081293 |
| 155 | regulation of synaptic vesicle transport (GO:1902803) | 2.75419493 |
| 156 | regulation of synapse maturation (GO:0090128) | 2.74431279 |
| 157 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.70964485 |
| 158 | mating behavior (GO:0007617) | 2.65809912 |
| 159 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.65684596 |
| 160 | fear response (GO:0042596) | 2.65074105 |
| 161 | growth hormone secretion (GO:0030252) | 2.62577948 |
| 162 | artery smooth muscle contraction (GO:0014824) | 2.61263998 |
| 163 | negative regulation of DNA biosynthetic process (GO:2000279) | 2.59611539 |
| 164 | vocalization behavior (GO:0071625) | 2.59234661 |
| 165 | protein hydroxylation (GO:0018126) | 2.57772082 |
| 166 | transferrin transport (GO:0033572) | 2.56653648 |
| 167 | histone H4-K12 acetylation (GO:0043983) | 2.55701432 |
| 168 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.50361781 |
| 169 | regulation of vesicle fusion (GO:0031338) | 2.49821777 |
| 170 | neuromuscular process controlling balance (GO:0050885) | 2.48479414 |
| 171 | long term synaptic depression (GO:0060292) | 2.47632064 |
| 172 | cellular sodium ion homeostasis (GO:0006883) | 2.47512504 |
| 173 | dendritic spine organization (GO:0097061) | 2.47082265 |
| 174 | layer formation in cerebral cortex (GO:0021819) | 2.47077796 |
| 175 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.44388983 |
| 176 | Golgi transport vesicle coating (GO:0048200) | 2.42614644 |
| 177 | COPI coating of Golgi vesicle (GO:0048205) | 2.42614644 |
| 178 | regulation of gonadotropin secretion (GO:0032276) | 2.41337668 |
| 179 | establishment of mitochondrion localization (GO:0051654) | 2.40864448 |
| 180 | synaptic vesicle endocytosis (GO:0048488) | 2.39938159 |
| 181 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.39785921 |
| 182 | cerebellar Purkinje cell layer development (GO:0021680) | 2.39438182 |
| 183 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.37171225 |
| 184 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.37028281 |
| 185 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 2.36422584 |
| 186 | ferric iron transport (GO:0015682) | 2.35148986 |
| 187 | trivalent inorganic cation transport (GO:0072512) | 2.35148986 |
| 188 | regulation of synaptic plasticity (GO:0048167) | 2.34766084 |
| 189 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.34459592 |
| 190 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.33976104 |
| 191 | cAMP biosynthetic process (GO:0006171) | 2.29372113 |
| 192 | proline metabolic process (GO:0006560) | 2.28278955 |
| 193 | tonic smooth muscle contraction (GO:0014820) | 2.27943174 |
| 194 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.27899814 |
| 195 | phosphate ion transport (GO:0006817) | 2.27724477 |
| 196 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.27453717 |
| 197 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.27453717 |
| 198 | response to lipoprotein particle (GO:0055094) | 2.26634839 |
| 199 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.25866836 |
| 200 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.25372505 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 5.80110715 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.42976640 |
| 3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.91877208 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.76639235 |
| 5 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.54950037 |
| 6 | GATA1_22025678_ChIP-Seq_K562_Human | 3.31029256 |
| 7 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 3.07765755 |
| 8 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.87998497 |
| 9 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.84899329 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.69282156 |
| 11 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.67561139 |
| 12 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.61629411 |
| 13 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.48785403 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.46926799 |
| 15 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.39710686 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.37949062 |
| 17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.32143115 |
| 18 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 2.30833382 |
| 19 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.26116283 |
| 20 | GATA1_19941826_ChIP-Seq_K562_Human | 2.24711712 |
| 21 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.22758831 |
| 22 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.22435018 |
| 23 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.22435018 |
| 24 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.05815263 |
| 25 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 2.05074671 |
| 26 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.03398853 |
| 27 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.03398853 |
| 28 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.02804594 |
| 29 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.02054800 |
| 30 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.01994470 |
| 31 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.00194088 |
| 32 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.99507205 |
| 33 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.97830253 |
| 34 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.97434191 |
| 35 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.96713812 |
| 36 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.95922361 |
| 37 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94702080 |
| 38 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.93060224 |
| 39 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.92117921 |
| 40 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.91922396 |
| 41 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.91214252 |
| 42 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.91108122 |
| 43 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.90960062 |
| 44 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.90123731 |
| 45 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.89364416 |
| 46 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.86434715 |
| 47 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.85240316 |
| 48 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.79132253 |
| 49 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.78080317 |
| 50 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.76719146 |
| 51 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.75898337 |
| 52 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.75208765 |
| 53 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.75195445 |
| 54 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.71113329 |
| 55 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.70463236 |
| 56 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.70148603 |
| 57 | GATA2_19941826_ChIP-Seq_K562_Human | 1.68966174 |
| 58 | KDM2B_26808549_Chip-Seq_K562_Human | 1.67850250 |
| 59 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66887177 |
| 60 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.66740015 |
| 61 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.64540092 |
| 62 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.63959693 |
| 63 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.63644303 |
| 64 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.63579955 |
| 65 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.62157296 |
| 66 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.61265285 |
| 67 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.59947811 |
| 68 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.59822329 |
| 69 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.59686818 |
| 70 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.56972078 |
| 71 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.55556599 |
| 72 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.53618116 |
| 73 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.52195118 |
| 74 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.52110972 |
| 75 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.51714287 |
| 76 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.51083174 |
| 77 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.50492811 |
| 78 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.49916951 |
| 79 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.49913574 |
| 80 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.49434344 |
| 81 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.49401671 |
| 82 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.49056982 |
| 83 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.45074919 |
| 84 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.44914742 |
| 85 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.44839816 |
| 86 | SPI1_23127762_ChIP-Seq_K562_Human | 1.44326462 |
| 87 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.43051423 |
| 88 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.42658365 |
| 89 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.42483287 |
| 90 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.41673134 |
| 91 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.40384766 |
| 92 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.39509782 |
| 93 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.39065729 |
| 94 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.39049373 |
| 95 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.38251841 |
| 96 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.37860057 |
| 97 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.36237540 |
| 98 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.36165909 |
| 99 | MAF_26560356_Chip-Seq_TH1_Human | 1.34405687 |
| 100 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.34280424 |
| 101 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.33667204 |
| 102 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.33599927 |
| 103 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.33598258 |
| 104 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.32715997 |
| 105 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.31172807 |
| 106 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.30344446 |
| 107 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.30073242 |
| 108 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.29340726 |
| 109 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.28650830 |
| 110 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.27147059 |
| 111 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.26955584 |
| 112 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.21770279 |
| 113 | MYC_22102868_ChIP-Seq_BL_Human | 1.21587294 |
| 114 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.20746348 |
| 115 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20567245 |
| 116 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.19921993 |
| 117 | * EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.19029955 |
| 118 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.18661103 |
| 119 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.18608435 |
| 120 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.18016950 |
| 121 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.17975207 |
| 122 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.17360126 |
| 123 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.15552028 |
| 124 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.15347268 |
| 125 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.15003291 |
| 126 | MYB_26560356_Chip-Seq_TH2_Human | 1.14247708 |
| 127 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13419453 |
| 128 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.13020468 |
| 129 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.12886543 |
| 130 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.12821826 |
| 131 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.11569919 |
| 132 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.11549852 |
| 133 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.11306256 |
| 134 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.10090133 |
| 135 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.10048974 |
| 136 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.09786182 |
| 137 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.09247511 |
| 138 | UTX_26944678_Chip-Seq_JUKART_Human | 1.09140538 |
| 139 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.08744592 |
| 140 | * RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.08375605 |
| 141 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08128625 |
| 142 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.07147444 |
| 143 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.07127494 |
| 144 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06305291 |
| 145 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.06248531 |
| 146 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.05953857 |
| 147 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.05452244 |
| 148 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.04341446 |
| 149 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.04007367 |
| 150 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.03967348 |
| 151 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.03376516 |
| 152 | P68_20966046_ChIP-Seq_HELA_Human | 1.03169555 |
| 153 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.02421808 |
| 154 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.01466165 |
| 155 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.00209941 |
| 156 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.99918689 |
| 157 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99260908 |
| 158 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.99134597 |
| 159 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.98829240 |
| 160 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.98748383 |
| 161 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.97963201 |
| 162 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.97561380 |
| 163 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.96642613 |
| 164 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.96408666 |
| 165 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.96356619 |
| 166 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.96103305 |
| 167 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.95522729 |
| 168 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.94776385 |
| 169 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.94129463 |
| 170 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93375726 |
| 171 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.91563428 |
| 172 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.91554005 |
| 173 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.91545588 |
| 174 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.91350037 |
| 175 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.90222383 |
| 176 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.89071909 |
| 177 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.88722973 |
| 178 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.88632331 |
| 179 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.88005075 |
| 180 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.87998328 |
| 181 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.87841889 |
| 182 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.87221989 |
| 183 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.86374624 |
| 184 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.85576730 |
| 185 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.85406373 |
| 186 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.85116537 |
| 187 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.84598224 |
| 188 | MITF_21258399_ChIP-Seq_MELANOMA_Human | 0.82576774 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 5.64374030 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 5.19606234 |
| 3 | MP0000751_myopathy | 4.46622586 |
| 4 | MP0004147_increased_porphyrin_level | 4.35092137 |
| 5 | MP0004859_abnormal_synaptic_plasticity | 4.12311367 |
| 6 | MP0000749_muscle_degeneration | 4.08824809 |
| 7 | MP0004084_abnormal_cardiac_muscle | 4.04582956 |
| 8 | MP0004215_abnormal_myocardial_fiber | 3.83579032 |
| 9 | MP0003656_abnormal_erythrocyte_physiolo | 3.81121870 |
| 10 | MP0003705_abnormal_hypodermis_morpholog | 3.53621456 |
| 11 | MP0004036_abnormal_muscle_relaxation | 3.35202556 |
| 12 | MP0009780_abnormal_chondrocyte_physiolo | 3.28715932 |
| 13 | MP0000013_abnormal_adipose_tissue | 2.98330704 |
| 14 | MP0004270_analgesia | 2.97729785 |
| 15 | MP0004145_abnormal_muscle_electrophysio | 2.89055384 |
| 16 | MP0005330_cardiomyopathy | 2.84680862 |
| 17 | MP0005646_abnormal_pituitary_gland | 2.82408744 |
| 18 | MP0008775_abnormal_heart_ventricle | 2.79802216 |
| 19 | MP0003880_abnormal_central_pattern | 2.54275428 |
| 20 | MP0002106_abnormal_muscle_physiology | 2.51837207 |
| 21 | MP0004087_abnormal_muscle_fiber | 2.50649985 |
| 22 | MP0002736_abnormal_nociception_after | 2.43890319 |
| 23 | MP0003635_abnormal_synaptic_transmissio | 2.40356124 |
| 24 | MP0005423_abnormal_somatic_nervous | 2.35722099 |
| 25 | MP0002972_abnormal_cardiac_muscle | 2.30921808 |
| 26 | MP0002269_muscular_atrophy | 2.29220999 |
| 27 | MP0004130_abnormal_muscle_cell | 2.24195706 |
| 28 | MP0006036_abnormal_mitochondrial_physio | 2.23167499 |
| 29 | MP0000747_muscle_weakness | 2.22948076 |
| 30 | MP0004885_abnormal_endolymph | 2.22214819 |
| 31 | MP0005620_abnormal_muscle_contractility | 2.14765247 |
| 32 | MP0001968_abnormal_touch/_nociception | 2.13084889 |
| 33 | MP0000750_abnormal_muscle_regeneration | 2.06989279 |
| 34 | MP0000759_abnormal_skeletal_muscle | 2.04250961 |
| 35 | MP0005369_muscle_phenotype | 2.03438370 |
| 36 | MP0005360_urolithiasis | 2.03024088 |
| 37 | MP0003183_abnormal_peptide_metabolism | 2.02117474 |
| 38 | MP0004510_myositis | 1.99659148 |
| 39 | MP0005385_cardiovascular_system_phenoty | 1.97906611 |
| 40 | MP0001544_abnormal_cardiovascular_syste | 1.97906611 |
| 41 | MP0002734_abnormal_mechanical_nocicepti | 1.94279629 |
| 42 | MP0002063_abnormal_learning/memory/cond | 1.93429689 |
| 43 | MP0001486_abnormal_startle_reflex | 1.89726214 |
| 44 | MP0010630_abnormal_cardiac_muscle | 1.85249343 |
| 45 | MP0004484_altered_response_of | 1.81334910 |
| 46 | MP0002064_seizures | 1.81309945 |
| 47 | MP0003137_abnormal_impulse_conducting | 1.79214414 |
| 48 | MP0001661_extended_life_span | 1.77266783 |
| 49 | MP0003828_pulmonary_edema | 1.75752180 |
| 50 | MP0000003_abnormal_adipose_tissue | 1.73732817 |
| 51 | MP0000343_altered_response_to | 1.67167328 |
| 52 | MP0002735_abnormal_chemical_nociception | 1.65114760 |
| 53 | MP0008569_lethality_at_weaning | 1.63723477 |
| 54 | MP0002272_abnormal_nervous_system | 1.61509347 |
| 55 | MP0009745_abnormal_behavioral_response | 1.58227975 |
| 56 | MP0009046_muscle_twitch | 1.57685529 |
| 57 | MP0006138_congestive_heart_failure | 1.56539318 |
| 58 | MP0002572_abnormal_emotion/affect_behav | 1.53219641 |
| 59 | MP0005397_hematopoietic_system_phenotyp | 1.46509063 |
| 60 | MP0001545_abnormal_hematopoietic_system | 1.46509063 |
| 61 | MP0003122_maternal_imprinting | 1.46263845 |
| 62 | MP0000534_abnormal_ureter_morphology | 1.45604739 |
| 63 | MP0001270_distended_abdomen | 1.39176660 |
| 64 | MP0002332_abnormal_exercise_endurance | 1.38807043 |
| 65 | MP0003329_amyloid_beta_deposits | 1.38570479 |
| 66 | MP0004085_abnormal_heartbeat | 1.38136734 |
| 67 | MP0002184_abnormal_innervation | 1.38057405 |
| 68 | MP0003221_abnormal_cardiomyocyte_apopto | 1.35187978 |
| 69 | MP0008995_early_reproductive_senescence | 1.35095986 |
| 70 | MP0005670_abnormal_white_adipose | 1.29831070 |
| 71 | MP0001502_abnormal_circadian_rhythm | 1.27694707 |
| 72 | MP0002822_catalepsy | 1.25387427 |
| 73 | MP0005410_abnormal_fertilization | 1.23517628 |
| 74 | MP0006054_spinal_hemorrhage | 1.23397578 |
| 75 | MP0003279_aneurysm | 1.21784071 |
| 76 | MP0003123_paternal_imprinting | 1.18955013 |
| 77 | MP0001835_abnormal_antigen_presentation | 1.16948284 |
| 78 | MP0010030_abnormal_orbit_morphology | 1.15836921 |
| 79 | MP0004185_abnormal_adipocyte_glucose | 1.13516786 |
| 80 | MP0000681_abnormal_thyroid_gland | 1.12113210 |
| 81 | MP0005623_abnormal_meninges_morphology | 1.12058661 |
| 82 | MP0000955_abnormal_spinal_cord | 1.11844794 |
| 83 | MP0006276_abnormal_autonomic_nervous | 1.11794416 |
| 84 | MP0002066_abnormal_motor_capabilities/c | 1.11025209 |
| 85 | MP0003283_abnormal_digestive_organ | 1.09797793 |
| 86 | MP0002249_abnormal_larynx_morphology | 1.04678498 |
| 87 | MP0004233_abnormal_muscle_weight | 1.04674525 |
| 88 | MP0006035_abnormal_mitochondrial_morpho | 1.04581576 |
| 89 | MP0002396_abnormal_hematopoietic_system | 1.01580393 |
| 90 | MP0004808_abnormal_hematopoietic_stem | 0.99552126 |
| 91 | MP0002733_abnormal_thermal_nociception | 0.98496165 |
| 92 | MP0001853_heart_inflammation | 0.97925198 |
| 93 | MP0001440_abnormal_grooming_behavior | 0.97407376 |
| 94 | MP0003942_abnormal_urinary_system | 0.97207759 |
| 95 | MP0002877_abnormal_melanocyte_morpholog | 0.96874928 |
| 96 | MP0000678_abnormal_parathyroid_gland | 0.95989139 |
| 97 | MP0002067_abnormal_sensory_capabilities | 0.95593764 |
| 98 | MP0001984_abnormal_olfaction | 0.95471021 |
| 99 | MP0001970_abnormal_pain_threshold | 0.95029292 |
| 100 | MP0002882_abnormal_neuron_morphology | 0.94927984 |
| 101 | MP0005666_abnormal_adipose_tissue | 0.93400161 |
| 102 | MP0002938_white_spotting | 0.92708898 |
| 103 | MP0002229_neurodegeneration | 0.92408639 |
| 104 | MP0000566_synostosis | 0.92231252 |
| 105 | MP0002557_abnormal_social/conspecific_i | 0.91630474 |
| 106 | MP0003633_abnormal_nervous_system | 0.91620338 |
| 107 | MP0003634_abnormal_glial_cell | 0.91120779 |
| 108 | MP0005266_abnormal_metabolism | 0.90140547 |
| 109 | MP0002132_abnormal_respiratory_system | 0.89524254 |
| 110 | MP0000266_abnormal_heart_morphology | 0.89225816 |
| 111 | MP0002295_abnormal_pulmonary_circulatio | 0.88139842 |
| 112 | MP0000920_abnormal_myelination | 0.87638995 |
| 113 | MP0002127_abnormal_cardiovascular_syste | 0.87140290 |
| 114 | MP0000685_abnormal_immune_system | 0.86560836 |
| 115 | MP0009785_altered_susceptibility_to | 0.85213357 |
| 116 | MP0005367_renal/urinary_system_phenotyp | 0.84236334 |
| 117 | MP0000516_abnormal_urinary_system | 0.84236334 |
| 118 | MP0003567_abnormal_fetal_cardiomyocyte | 0.84159687 |
| 119 | MP0005464_abnormal_platelet_physiology | 0.83909926 |
| 120 | MP0000026_abnormal_inner_ear | 0.83148105 |
| 121 | MP0003724_increased_susceptibility_to | 0.81102019 |
| 122 | MP0000762_abnormal_tongue_morphology | 0.80618635 |
| 123 | MP0003631_nervous_system_phenotype | 0.80482297 |
| 124 | MP0002069_abnormal_eating/drinking_beha | 0.80432041 |
| 125 | MP0004811_abnormal_neuron_physiology | 0.79957115 |
| 126 | MP0001963_abnormal_hearing_physiology | 0.79504799 |
| 127 | MP0001299_abnormal_eye_distance/ | 0.79485077 |
| 128 | MP0003806_abnormal_nucleotide_metabolis | 0.79285708 |
| 129 | MP0001849_ear_inflammation | 0.78960677 |
| 130 | MP0005671_abnormal_response_to | 0.78293945 |
| 131 | MP0005165_increased_susceptibility_to | 0.78225212 |
| 132 | MP0005332_abnormal_amino_acid | 0.77707078 |
| 133 | MP0005551_abnormal_eye_electrophysiolog | 0.76154646 |
| 134 | MP0005083_abnormal_biliary_tract | 0.75111592 |
| 135 | MP0002108_abnormal_muscle_morphology | 0.74944517 |
| 136 | MP0002896_abnormal_bone_mineralization | 0.74558669 |
| 137 | MP0002148_abnormal_hypersensitivity_rea | 0.74076211 |
| 138 | MP0001905_abnormal_dopamine_level | 0.73867987 |
| 139 | MP0002419_abnormal_innate_immunity | 0.71732770 |
| 140 | MP0000631_abnormal_neuroendocrine_gland | 0.71475903 |
| 141 | MP0001756_abnormal_urination | 0.71258660 |
| 142 | MP0003191_abnormal_cellular_cholesterol | 0.71203633 |
| 143 | MP0005025_abnormal_response_to | 0.69576057 |
| 144 | MP0000733_abnormal_muscle_development | 0.69131484 |
| 145 | MP0002398_abnormal_bone_marrow | 0.68572041 |
| 146 | MP0001501_abnormal_sleep_pattern | 0.68109356 |
| 147 | MP0000230_abnormal_systemic_arterial | 0.68075013 |
| 148 | MP0004043_abnormal_pH_regulation | 0.67685589 |
| 149 | MP0000778_abnormal_nervous_system | 0.67610569 |
| 150 | MP0004858_abnormal_nervous_system | 0.67294580 |
| 151 | MP0001348_abnormal_lacrimal_gland | 0.67153379 |
| 152 | MP0002089_abnormal_postnatal_growth/wei | 0.66912273 |
| 153 | MP0001944_abnormal_pancreas_morphology | 0.66865388 |
| 154 | MP0005319_abnormal_enzyme/_coenzyme | 0.64997694 |
| 155 | MP0001340_abnormal_eyelid_morphology | 0.64976502 |
| 156 | MP0002128_abnormal_blood_circulation | 0.64313887 |
| 157 | MP0005636_abnormal_mineral_homeostasis | 0.64193048 |
| 158 | MP0003436_decreased_susceptibility_to | 0.64056204 |
| 159 | MP0002909_abnormal_adrenal_gland | 0.63721589 |
| 160 | MP0003878_abnormal_ear_physiology | 0.62177064 |
| 161 | MP0005377_hearing/vestibular/ear_phenot | 0.62177064 |
| 162 | MP0001790_abnormal_immune_system | 0.61927316 |
| 163 | MP0005387_immune_system_phenotype | 0.61927316 |
| 164 | MP0003566_abnormal_cell_adhesion | 0.61397928 |
| 165 | MP0005000_abnormal_immune_tolerance | 0.60181808 |
| 166 | MP0005058_abnormal_lysosome_morphology | 0.59544743 |
| 167 | MP0000358_abnormal_cell_content/ | 0.58385423 |
| 168 | MP0008469_abnormal_protein_level | 0.57461017 |
| 169 | MP0009278_abnormal_bone_marrow | 0.56672322 |
| 170 | MP0002078_abnormal_glucose_homeostasis | 0.56309825 |
| 171 | MP0002429_abnormal_blood_cell | 0.55525876 |
| 172 | MP0002722_abnormal_immune_system | 0.55325649 |
| 173 | MP0002723_abnormal_immune_serum | 0.53058898 |
| 174 | MP0003186_abnormal_redox_activity | 0.52394823 |
| 175 | MP0010368_abnormal_lymphatic_system | 0.51974662 |
| 176 | MP0002405_respiratory_system_inflammati | 0.51475655 |
| 177 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.50213817 |
| 178 | MP0005503_abnormal_tendon_morphology | 0.49861111 |
| 179 | MP0000689_abnormal_spleen_morphology | 0.49752117 |
| 180 | MP0001879_abnormal_lymphatic_vessel | 0.49715427 |
| 181 | MP0001819_abnormal_immune_cell | 0.49637275 |
| 182 | MP0003763_abnormal_thymus_physiology | 0.48676454 |
| 183 | MP0002420_abnormal_adaptive_immunity | 0.48537765 |
| 184 | MP0002452_abnormal_antigen_presenting | 0.48344012 |
| 185 | MP0008438_abnormal_cutaneous_collagen | 0.47382823 |
| 186 | MP0003879_abnormal_hair_cell | 0.47072184 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced muscle cramps (HP:0003710) | 6.22696395 |
| 2 | Exercise-induced myalgia (HP:0003738) | 5.99818870 |
| 3 | Action tremor (HP:0002345) | 5.62147744 |
| 4 | Calf muscle hypertrophy (HP:0008981) | 5.49491415 |
| 5 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.32872456 |
| 6 | Sudden death (HP:0001699) | 5.27252610 |
| 7 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 5.12337879 |
| 8 | Myoglobinuria (HP:0002913) | 5.11867702 |
| 9 | Ventricular tachycardia (HP:0004756) | 4.91253412 |
| 10 | Subaortic stenosis (HP:0001682) | 4.35770792 |
| 11 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.35770792 |
| 12 | Asymmetric septal hypertrophy (HP:0001670) | 4.28515837 |
| 13 | Muscle fiber splitting (HP:0003555) | 4.20371974 |
| 14 | Rhabdomyolysis (HP:0003201) | 4.10083749 |
| 15 | Lipoatrophy (HP:0100578) | 4.08654522 |
| 16 | Atrial fibrillation (HP:0005110) | 4.08044321 |
| 17 | Abnormality of the calf musculature (HP:0001430) | 4.07932329 |
| 18 | Myokymia (HP:0002411) | 3.91946662 |
| 19 | Supraventricular tachycardia (HP:0004755) | 3.79156082 |
| 20 | Primary atrial arrhythmia (HP:0001692) | 3.79017737 |
| 21 | Esophageal varix (HP:0002040) | 3.77989141 |
| 22 | Supraventricular arrhythmia (HP:0005115) | 3.69822562 |
| 23 | Hyporeflexia of lower limbs (HP:0002600) | 3.66487637 |
| 24 | Palpitations (HP:0001962) | 3.61525664 |
| 25 | Increased connective tissue (HP:0009025) | 3.53036245 |
| 26 | EMG: myopathic abnormalities (HP:0003458) | 3.50538817 |
| 27 | Ankle clonus (HP:0011448) | 3.49112146 |
| 28 | Myotonia (HP:0002486) | 3.49000264 |
| 29 | Dilated cardiomyopathy (HP:0001644) | 3.48793042 |
| 30 | Heterochromia iridis (HP:0001100) | 3.47348946 |
| 31 | Bundle branch block (HP:0011710) | 3.41788233 |
| 32 | Muscle fiber inclusion bodies (HP:0100299) | 3.30980566 |
| 33 | Constricted visual fields (HP:0001133) | 3.30583165 |
| 34 | Hepatic necrosis (HP:0002605) | 3.22040941 |
| 35 | White forelock (HP:0002211) | 3.20323916 |
| 36 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.18407234 |
| 37 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.15952769 |
| 38 | Abnormal umbilical cord blood vessels (HP:0011403) | 3.05622925 |
| 39 | Single umbilical artery (HP:0001195) | 3.05622925 |
| 40 | Abnormality of the fetal cardiovascular system (HP:0010948) | 3.05622925 |
| 41 | Muscle stiffness (HP:0003552) | 3.04160709 |
| 42 | Acute necrotizing encephalopathy (HP:0006965) | 2.99948438 |
| 43 | Type 1 muscle fiber predominance (HP:0003803) | 2.96268614 |
| 44 | Hepatocellular necrosis (HP:0001404) | 2.92776132 |
| 45 | Difficulty running (HP:0009046) | 2.90252446 |
| 46 | Syncope (HP:0001279) | 2.88432921 |
| 47 | Congenital sensorineural hearing impairment (HP:0008527) | 2.81389390 |
| 48 | Difficulty climbing stairs (HP:0003551) | 2.78525551 |
| 49 | Focal motor seizures (HP:0011153) | 2.78484144 |
| 50 | Heart block (HP:0012722) | 2.72213093 |
| 51 | Intention tremor (HP:0002080) | 2.68761602 |
| 52 | Mitochondrial inheritance (HP:0001427) | 2.68112116 |
| 53 | Patchy hypopigmentation of hair (HP:0011365) | 2.66937893 |
| 54 | Prolonged QT interval (HP:0001657) | 2.66754266 |
| 55 | Oligomenorrhea (HP:0000876) | 2.66195624 |
| 56 | Increased muscle lipid content (HP:0009058) | 2.65324514 |
| 57 | Biconcave vertebral bodies (HP:0004586) | 2.64608248 |
| 58 | Diaphragmatic weakness (HP:0009113) | 2.64445109 |
| 59 | Reticulocytosis (HP:0001923) | 2.64358543 |
| 60 | Abnormal atrioventricular conduction (HP:0005150) | 2.64205791 |
| 61 | Fatigue (HP:0012378) | 2.62778518 |
| 62 | Focal seizures (HP:0007359) | 2.61139796 |
| 63 | Abnormality of the lower motor neuron (HP:0002366) | 2.60976094 |
| 64 | Supranuclear gaze palsy (HP:0000605) | 2.60271467 |
| 65 | Esophageal neoplasm (HP:0100751) | 2.58102509 |
| 66 | Neoplasm of head and neck (HP:0012288) | 2.58102509 |
| 67 | Visceral angiomatosis (HP:0100761) | 2.57988489 |
| 68 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.57781766 |
| 69 | Nemaline bodies (HP:0003798) | 2.57520558 |
| 70 | Hypoalphalipoproteinemia (HP:0003233) | 2.55377870 |
| 71 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.54368789 |
| 72 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.54368789 |
| 73 | Distal upper limb amyotrophy (HP:0007149) | 2.52894352 |
| 74 | Upper limb amyotrophy (HP:0009129) | 2.52894352 |
| 75 | Areflexia of lower limbs (HP:0002522) | 2.50112120 |
| 76 | Increased intramyocellular lipid droplets (HP:0012240) | 2.49642780 |
| 77 | Increased CSF lactate (HP:0002490) | 2.49106519 |
| 78 | Hand muscle atrophy (HP:0009130) | 2.47458008 |
| 79 | Exercise intolerance (HP:0003546) | 2.46866474 |
| 80 | Cholelithiasis (HP:0001081) | 2.45877029 |
| 81 | Depression (HP:0000716) | 2.45402898 |
| 82 | Ventricular arrhythmia (HP:0004308) | 2.43002367 |
| 83 | Atonic seizures (HP:0010819) | 2.41029537 |
| 84 | Acute encephalopathy (HP:0006846) | 2.40862293 |
| 85 | Poikilocytosis (HP:0004447) | 2.40680471 |
| 86 | Right ventricular cardiomyopathy (HP:0011663) | 2.38671637 |
| 87 | Myocardial infarction (HP:0001658) | 2.36746075 |
| 88 | Ketoacidosis (HP:0001993) | 2.35150860 |
| 89 | Clonus (HP:0002169) | 2.31383440 |
| 90 | Lactic acidosis (HP:0003128) | 2.30540850 |
| 91 | Hypoglycemic coma (HP:0001325) | 2.29499405 |
| 92 | Progressive macrocephaly (HP:0004481) | 2.29213303 |
| 93 | Hemangiomatosis (HP:0007461) | 2.29136530 |
| 94 | Distal arthrogryposis (HP:0005684) | 2.28819444 |
| 95 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.28397087 |
| 96 | Spastic gait (HP:0002064) | 2.26888300 |
| 97 | Spontaneous hematomas (HP:0007420) | 2.26281588 |
| 98 | Ulnar deviation of the wrist (HP:0003049) | 2.25473554 |
| 99 | Increased variability in muscle fiber diameter (HP:0003557) | 2.24762468 |
| 100 | Cerebral hypomyelination (HP:0006808) | 2.24402955 |
| 101 | Abnormality of the umbilical cord (HP:0010881) | 2.24091572 |
| 102 | Truncal ataxia (HP:0002078) | 2.23196568 |
| 103 | Abnormal number of erythroid precursors (HP:0012131) | 2.22758008 |
| 104 | Atrioventricular block (HP:0001678) | 2.22707893 |
| 105 | Distal lower limb muscle weakness (HP:0009053) | 2.22485703 |
| 106 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.20174929 |
| 107 | Abnormality of alanine metabolism (HP:0010916) | 2.20174929 |
| 108 | Hyperalaninemia (HP:0003348) | 2.20174929 |
| 109 | Myopathic facies (HP:0002058) | 2.18620130 |
| 110 | Back pain (HP:0003418) | 2.17528407 |
| 111 | Polycythemia (HP:0001901) | 2.17309467 |
| 112 | Nausea (HP:0002018) | 2.17138028 |
| 113 | Abnormality of the tricuspid valve (HP:0001702) | 2.15341781 |
| 114 | Conjugated hyperbilirubinemia (HP:0002908) | 2.14959951 |
| 115 | Petechiae (HP:0000967) | 2.12161022 |
| 116 | Dysmetria (HP:0001310) | 2.10699182 |
| 117 | Thin ribs (HP:0000883) | 2.10505181 |
| 118 | Tinnitus (HP:0000360) | 2.10165973 |
| 119 | Neck muscle weakness (HP:0000467) | 2.09894772 |
| 120 | Abnormal gallbladder morphology (HP:0012437) | 2.09610522 |
| 121 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.08573986 |
| 122 | Hypoplastic left heart (HP:0004383) | 2.08572480 |
| 123 | Maternal diabetes (HP:0009800) | 2.08032547 |
| 124 | Limb-girdle muscle atrophy (HP:0003797) | 2.07979734 |
| 125 | Abnormal EKG (HP:0003115) | 2.07717075 |
| 126 | Protrusio acetabuli (HP:0003179) | 2.07633744 |
| 127 | Left ventricular hypertrophy (HP:0001712) | 2.06781004 |
| 128 | Progressive muscle weakness (HP:0003323) | 2.05550553 |
| 129 | Respiratory failure (HP:0002878) | 2.05547103 |
| 130 | Abnormality of glycolysis (HP:0004366) | 2.05329227 |
| 131 | Ragged-red muscle fibers (HP:0003200) | 2.05207318 |
| 132 | Insomnia (HP:0100785) | 2.04471693 |
| 133 | Neuroendocrine neoplasm (HP:0100634) | 2.04016780 |
| 134 | Pheochromocytoma (HP:0002666) | 2.02833345 |
| 135 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.01254824 |
| 136 | Epileptic encephalopathy (HP:0200134) | 2.00750975 |
| 137 | Generalized aminoaciduria (HP:0002909) | 2.00247665 |
| 138 | Hammertoe (HP:0001765) | 1.99659216 |
| 139 | Increased serum ferritin (HP:0003281) | 1.98935262 |
| 140 | Facial diplegia (HP:0001349) | 1.96076760 |
| 141 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.93124085 |
| 142 | Dicarboxylic aciduria (HP:0003215) | 1.93124085 |
| 143 | Large for gestational age (HP:0001520) | 1.92313393 |
| 144 | Poor speech (HP:0002465) | 1.92250908 |
| 145 | Generalized muscle weakness (HP:0003324) | 1.91150506 |
| 146 | Muscular dystrophy (HP:0003560) | 1.90877328 |
| 147 | Rimmed vacuoles (HP:0003805) | 1.90684013 |
| 148 | Cerebral edema (HP:0002181) | 1.90074229 |
| 149 | Prolonged bleeding time (HP:0003010) | 1.90027712 |
| 150 | Abnormality of the nasal mucosa (HP:0000433) | 1.89862900 |
| 151 | Increased serum pyruvate (HP:0003542) | 1.89459596 |
| 152 | Testicular atrophy (HP:0000029) | 1.87865088 |
| 153 | Tubulointerstitial nephritis (HP:0001970) | 1.87010074 |
| 154 | Akinesia (HP:0002304) | 1.84817339 |
| 155 | Febrile seizures (HP:0002373) | 1.83217855 |
| 156 | Obstructive sleep apnea (HP:0002870) | 1.82520668 |
| 157 | Ileus (HP:0002595) | 1.81033885 |
| 158 | Hypopigmentation of the fundus (HP:0007894) | 1.79260996 |
| 159 | Rapidly progressive (HP:0003678) | 1.78278924 |
| 160 | Urinary incontinence (HP:0000020) | 1.77512270 |
| 161 | Abnormality of carpal bone ossification (HP:0006257) | 1.74988483 |
| 162 | Postural tremor (HP:0002174) | 1.74909923 |
| 163 | Spinal canal stenosis (HP:0003416) | 1.74254835 |
| 164 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.73091809 |
| 165 | Athetosis (HP:0002305) | 1.68529826 |
| 166 | Abnormality of the corticospinal tract (HP:0002492) | 1.68503336 |
| 167 | Lower limb muscle weakness (HP:0007340) | 1.68317680 |
| 168 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.68069319 |
| 169 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.67954766 |
| 170 | Delusions (HP:0000746) | 1.66553964 |
| 171 | Venous abnormality (HP:0002624) | 1.66515699 |
| 172 | Hypoplastic heart (HP:0001961) | 1.66136093 |
| 173 | Premature rupture of membranes (HP:0001788) | 1.63697557 |
| 174 | Distal lower limb amyotrophy (HP:0008944) | 1.63380547 |
| 175 | Anxiety (HP:0000739) | 1.61087483 |
| 176 | Scanning speech (HP:0002168) | 1.61006191 |
| 177 | Lower limb amyotrophy (HP:0007210) | 1.60329611 |
| 178 | Neurofibrillary tangles (HP:0002185) | 1.58799283 |
| 179 | Hyperphosphatemia (HP:0002905) | 1.57898549 |
| 180 | Conjunctival telangiectasia (HP:0000524) | 1.56268613 |
| 181 | Growth hormone excess (HP:0000845) | 1.55106648 |
| 182 | Bowel incontinence (HP:0002607) | 1.54753196 |
| 183 | Decreased subcutaneous fat (HP:0001002) | 1.54124898 |
| 184 | Visual hallucinations (HP:0002367) | 1.53376930 |
| 185 | Homocystinuria (HP:0002156) | 1.52727362 |
| 186 | Abnormality of homocysteine metabolism (HP:0010919) | 1.52727362 |
| 187 | Urinary urgency (HP:0000012) | 1.52478801 |
| 188 | Progressive cerebellar ataxia (HP:0002073) | 1.51896312 |
| 189 | Cerebral aneurysm (HP:0004944) | 1.51643499 |
| 190 | Spinal rigidity (HP:0003306) | 1.51370238 |
| 191 | Absence seizures (HP:0002121) | 1.51017638 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 5.10030253 |
| 2 | OBSCN | 3.88119374 |
| 3 | PDK4 | 3.30892860 |
| 4 | PDK3 | 3.30892860 |
| 5 | PHKG2 | 3.08649758 |
| 6 | PHKG1 | 3.08649758 |
| 7 | NTRK3 | 2.90433706 |
| 8 | EPHA4 | 2.82121158 |
| 9 | NME2 | 2.63646088 |
| 10 | NTRK2 | 2.59225010 |
| 11 | MARK1 | 2.57676167 |
| 12 | MYLK | 2.46355400 |
| 13 | PAK6 | 2.35519693 |
| 14 | MUSK | 2.31756387 |
| 15 | TRIB3 | 2.15149368 |
| 16 | BCKDK | 2.13196378 |
| 17 | MAP2K3 | 2.07496187 |
| 18 | TIE1 | 2.03853194 |
| 19 | PKN2 | 2.03625329 |
| 20 | PINK1 | 1.94548930 |
| 21 | PDK2 | 1.90267409 |
| 22 | LMTK2 | 1.83999042 |
| 23 | UHMK1 | 1.82524922 |
| 24 | TGFBR2 | 1.76443691 |
| 25 | FLT3 | 1.76125494 |
| 26 | EPHA2 | 1.72837821 |
| 27 | KIT | 1.72256739 |
| 28 | ICK | 1.68994240 |
| 29 | EPHB2 | 1.68254953 |
| 30 | CDK9 | 1.66786970 |
| 31 | GRK7 | 1.59086114 |
| 32 | DAPK2 | 1.58223192 |
| 33 | SGK494 | 1.56356159 |
| 34 | SGK223 | 1.56356159 |
| 35 | NTRK1 | 1.55835826 |
| 36 | ZAK | 1.51146541 |
| 37 | RIPK1 | 1.47622525 |
| 38 | MAPKAPK3 | 1.44879310 |
| 39 | PRPF4B | 1.36099183 |
| 40 | MAP4K1 | 1.36091281 |
| 41 | NEK1 | 1.34066935 |
| 42 | CAMK2B | 1.31984657 |
| 43 | PIM2 | 1.30743222 |
| 44 | LATS2 | 1.25146398 |
| 45 | MAP3K9 | 1.23705902 |
| 46 | TAOK3 | 1.22401034 |
| 47 | TYK2 | 1.21402052 |
| 48 | DMPK | 1.21225480 |
| 49 | CDK5 | 1.17897761 |
| 50 | STK24 | 1.16949749 |
| 51 | TRPM7 | 1.14664246 |
| 52 | MAP3K11 | 1.14464021 |
| 53 | CAMKK1 | 1.14365388 |
| 54 | DAPK1 | 1.14245671 |
| 55 | SGK3 | 1.14073379 |
| 56 | JAK3 | 1.13885073 |
| 57 | NEK6 | 1.13732719 |
| 58 | SMG1 | 1.12840261 |
| 59 | TAOK2 | 1.09547874 |
| 60 | TBK1 | 1.08225849 |
| 61 | RPS6KB2 | 1.05969980 |
| 62 | CAMK2G | 1.05939988 |
| 63 | MINK1 | 1.05281060 |
| 64 | INSRR | 1.04636727 |
| 65 | MAP3K5 | 1.04624232 |
| 66 | ARAF | 1.04358144 |
| 67 | PIK3CA | 1.03862599 |
| 68 | MAPK12 | 1.03812851 |
| 69 | CCNB1 | 1.03509974 |
| 70 | EEF2K | 1.01641345 |
| 71 | TEC | 1.01600821 |
| 72 | PAK4 | 0.98933338 |
| 73 | KSR2 | 0.98820987 |
| 74 | TYRO3 | 0.98270806 |
| 75 | TXK | 0.96623753 |
| 76 | SGK2 | 0.95830350 |
| 77 | DYRK1B | 0.95577565 |
| 78 | MAP3K7 | 0.94403136 |
| 79 | STK38 | 0.93187972 |
| 80 | EIF2AK1 | 0.92827032 |
| 81 | PTK2 | 0.91062622 |
| 82 | BRSK1 | 0.90776794 |
| 83 | MARK2 | 0.89147987 |
| 84 | STK4 | 0.88795363 |
| 85 | PDGFRA | 0.87889066 |
| 86 | MST1R | 0.87636240 |
| 87 | CAMKK2 | 0.87221679 |
| 88 | KDR | 0.86024866 |
| 89 | SIK3 | 0.83552843 |
| 90 | JAK1 | 0.82511841 |
| 91 | TGFBR1 | 0.82363372 |
| 92 | MAP2K1 | 0.81807822 |
| 93 | FGR | 0.81406508 |
| 94 | LIMK1 | 0.80472085 |
| 95 | NEK9 | 0.79752645 |
| 96 | MAPK11 | 0.79462238 |
| 97 | MTOR | 0.76747408 |
| 98 | CDK19 | 0.74560964 |
| 99 | ERN1 | 0.73087786 |
| 100 | GRK5 | 0.72946853 |
| 101 | MAP2K6 | 0.72542120 |
| 102 | PRKCG | 0.72538627 |
| 103 | ZAP70 | 0.71922652 |
| 104 | PTK6 | 0.71381795 |
| 105 | MAPKAPK5 | 0.70864192 |
| 106 | RPS6KB1 | 0.69753433 |
| 107 | PDPK1 | 0.67974392 |
| 108 | SYK | 0.67806495 |
| 109 | JAK2 | 0.67494392 |
| 110 | DYRK2 | 0.65698875 |
| 111 | CASK | 0.65652862 |
| 112 | BTK | 0.65468240 |
| 113 | CAMK2A | 0.63693180 |
| 114 | AKT2 | 0.63609427 |
| 115 | NME1 | 0.61699271 |
| 116 | CDC42BPA | 0.61445996 |
| 117 | PRKAA2 | 0.60656793 |
| 118 | CDK8 | 0.59972715 |
| 119 | PIK3CG | 0.59844657 |
| 120 | CAMK1 | 0.59471819 |
| 121 | MET | 0.58086385 |
| 122 | IRAK3 | 0.58067266 |
| 123 | MAP3K3 | 0.57388419 |
| 124 | CDK15 | 0.55500617 |
| 125 | SIK2 | 0.54394436 |
| 126 | MARK3 | 0.53931138 |
| 127 | CDK11A | 0.53869995 |
| 128 | DYRK3 | 0.53547110 |
| 129 | ILK | 0.53171934 |
| 130 | CDK18 | 0.52628833 |
| 131 | CAMK4 | 0.51870570 |
| 132 | PTK2B | 0.51722617 |
| 133 | MATK | 0.51420565 |
| 134 | CAMK2D | 0.50953381 |
| 135 | MAP2K7 | 0.50760763 |
| 136 | PRKAA1 | 0.50250393 |
| 137 | IRAK2 | 0.49208185 |
| 138 | SIK1 | 0.49095257 |
| 139 | RPS6KC1 | 0.49010747 |
| 140 | RPS6KL1 | 0.49010747 |
| 141 | RPS6KA6 | 0.48563840 |
| 142 | ROCK2 | 0.47037745 |
| 143 | TESK1 | 0.46832012 |
| 144 | MAP3K1 | 0.45718036 |
| 145 | CDK14 | 0.45133142 |
| 146 | CSNK1A1 | 0.44662455 |
| 147 | VRK1 | 0.42975806 |
| 148 | PIM1 | 0.42347988 |
| 149 | MAP2K4 | 0.41114872 |
| 150 | MAPK10 | 0.40804326 |
| 151 | SCYL2 | 0.40091535 |
| 152 | DAPK3 | 0.39959133 |
| 153 | PLK2 | 0.39191125 |
| 154 | PAK2 | 0.38775346 |
| 155 | RPS6KA4 | 0.37931934 |
| 156 | IKBKB | 0.37515097 |
| 157 | ROCK1 | 0.37215309 |
| 158 | PRKCI | 0.36663007 |
| 159 | SGK1 | 0.36630955 |
| 160 | PDK1 | 0.35749465 |
| 161 | PRKG2 | 0.34396057 |
| 162 | MAPKAPK2 | 0.33957189 |
| 163 | IKBKE | 0.33729523 |
| 164 | EPHB1 | 0.33260297 |
| 165 | PRKD1 | 0.31916895 |
| 166 | BRSK2 | 0.29746818 |
| 167 | IRAK4 | 0.29727328 |
| 168 | PRKACG | 0.28384797 |
| 169 | WNK1 | 0.27746631 |
| 170 | PRKD3 | 0.27536972 |
| 171 | TAOK1 | 0.26975940 |
| 172 | WEE1 | 0.26105978 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.65356564 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.78476243 |
| 3 | Parkinsons disease_Homo sapiens_hsa05012 | 3.48990050 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.27463509 |
| 5 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.10685881 |
| 6 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.08402820 |
| 7 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 3.07532321 |
| 8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.06739288 |
| 9 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.79599793 |
| 10 | Nicotine addiction_Homo sapiens_hsa05033 | 2.66120716 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.65653023 |
| 12 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.59169735 |
| 13 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.52453809 |
| 14 | Alzheimers disease_Homo sapiens_hsa05010 | 2.47390386 |
| 15 | GABAergic synapse_Homo sapiens_hsa04727 | 2.36965505 |
| 16 | Huntingtons disease_Homo sapiens_hsa05016 | 2.29301682 |
| 17 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.12576292 |
| 18 | Carbon metabolism_Homo sapiens_hsa01200 | 2.11229120 |
| 19 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.09325942 |
| 20 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.08478786 |
| 21 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.08409526 |
| 22 | Morphine addiction_Homo sapiens_hsa05032 | 1.99567120 |
| 23 | Circadian entrainment_Homo sapiens_hsa04713 | 1.97615480 |
| 24 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.84757230 |
| 25 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.84523124 |
| 26 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.80490101 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.77241800 |
| 28 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.76518561 |
| 29 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.72149275 |
| 30 | Sulfur relay system_Homo sapiens_hsa04122 | 1.64632867 |
| 31 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.63603594 |
| 32 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.63536661 |
| 33 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.51594013 |
| 34 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.51182330 |
| 35 | Long-term potentiation_Homo sapiens_hsa04720 | 1.46772805 |
| 36 | Viral myocarditis_Homo sapiens_hsa05416 | 1.33520523 |
| 37 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.33423792 |
| 38 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.33240571 |
| 39 | Galactose metabolism_Homo sapiens_hsa00052 | 1.32814324 |
| 40 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.31163408 |
| 41 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.29134955 |
| 42 | Cocaine addiction_Homo sapiens_hsa05030 | 1.29121423 |
| 43 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.28709240 |
| 44 | DNA replication_Homo sapiens_hsa03030 | 1.28413949 |
| 45 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.22840497 |
| 46 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.22578698 |
| 47 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.17938390 |
| 48 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.15092728 |
| 49 | Insulin resistance_Homo sapiens_hsa04931 | 1.13508396 |
| 50 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.11788756 |
| 51 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.10876909 |
| 52 | Leishmaniasis_Homo sapiens_hsa05140 | 1.09671464 |
| 53 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.09242119 |
| 54 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.09182788 |
| 55 | Legionellosis_Homo sapiens_hsa05134 | 1.00493271 |
| 56 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.96926828 |
| 57 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.95738146 |
| 58 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.95665772 |
| 59 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.93993017 |
| 60 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.93952441 |
| 61 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.93788348 |
| 62 | Salivary secretion_Homo sapiens_hsa04970 | 0.93626705 |
| 63 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.91795636 |
| 64 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.90845813 |
| 65 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.90717117 |
| 66 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.90666331 |
| 67 | Prion diseases_Homo sapiens_hsa05020 | 0.90493675 |
| 68 | Circadian rhythm_Homo sapiens_hsa04710 | 0.89164722 |
| 69 | Long-term depression_Homo sapiens_hsa04730 | 0.88050285 |
| 70 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.87789410 |
| 71 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.87757504 |
| 72 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.86468599 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.84010082 |
| 74 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.82736639 |
| 75 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.79553025 |
| 76 | Taste transduction_Homo sapiens_hsa04742 | 0.79283809 |
| 77 | Glioma_Homo sapiens_hsa05214 | 0.78474536 |
| 78 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.78197557 |
| 79 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.76552131 |
| 80 | Measles_Homo sapiens_hsa05162 | 0.76025619 |
| 81 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.75319289 |
| 82 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.75101512 |
| 83 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.74709106 |
| 84 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.74165021 |
| 85 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.72163661 |
| 86 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.71577935 |
| 87 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.71356197 |
| 88 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.71229532 |
| 89 | Platelet activation_Homo sapiens_hsa04611 | 0.70247089 |
| 90 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.69999962 |
| 91 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.69847626 |
| 92 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.68323780 |
| 93 | Axon guidance_Homo sapiens_hsa04360 | 0.67963122 |
| 94 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.67830916 |
| 95 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.67775439 |
| 96 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.67295548 |
| 97 | Gap junction_Homo sapiens_hsa04540 | 0.66028334 |
| 98 | Bile secretion_Homo sapiens_hsa04976 | 0.65217559 |
| 99 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.64469789 |
| 100 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.64290159 |
| 101 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.61050609 |
| 102 | Tuberculosis_Homo sapiens_hsa05152 | 0.59667329 |
| 103 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.59075223 |
| 104 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.58954551 |
| 105 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.58512384 |
| 106 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.58153367 |
| 107 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.57978577 |
| 108 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.57049921 |
| 109 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.56278038 |
| 110 | Melanogenesis_Homo sapiens_hsa04916 | 0.56108895 |
| 111 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.55966961 |
| 112 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.52998993 |
| 113 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.52879313 |
| 114 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.52841833 |
| 115 | Other glycan degradation_Homo sapiens_hsa00511 | 0.52470534 |
| 116 | Olfactory transduction_Homo sapiens_hsa04740 | 0.51956894 |
| 117 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.51791558 |
| 118 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.49421866 |
| 119 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.47467672 |
| 120 | ABC transporters_Homo sapiens_hsa02010 | 0.47428705 |
| 121 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.47187186 |
| 122 | Ribosome_Homo sapiens_hsa03010 | 0.46155573 |
| 123 | Influenza A_Homo sapiens_hsa05164 | 0.46120079 |
| 124 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.45950492 |
| 125 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.45823289 |
| 126 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.45456092 |
| 127 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.44712890 |
| 128 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44377357 |
| 129 | Apoptosis_Homo sapiens_hsa04210 | 0.44073613 |
| 130 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.43817496 |
| 131 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.42962870 |
| 132 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.42593029 |
| 133 | Purine metabolism_Homo sapiens_hsa00230 | 0.42441172 |
| 134 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.41794974 |
| 135 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.40379290 |
| 136 | Metabolic pathways_Homo sapiens_hsa01100 | 0.39824525 |
| 137 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.39123306 |
| 138 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38719531 |
| 139 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.37448264 |
| 140 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.36862123 |
| 141 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.36725698 |
| 142 | Pertussis_Homo sapiens_hsa05133 | 0.35736371 |
| 143 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.35693951 |
| 144 | Malaria_Homo sapiens_hsa05144 | 0.35548320 |
| 145 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.35413875 |
| 146 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.35235917 |
| 147 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.32455153 |
| 148 | Base excision repair_Homo sapiens_hsa03410 | 0.31315108 |
| 149 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.30891084 |
| 150 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.30550803 |
| 151 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.28383922 |
| 152 | Focal adhesion_Homo sapiens_hsa04510 | 0.28114760 |
| 153 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.27148512 |
| 154 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.26999706 |
| 155 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24822216 |
| 156 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.24804798 |
| 157 | Hepatitis B_Homo sapiens_hsa05161 | 0.24442019 |
| 158 | Lysosome_Homo sapiens_hsa04142 | 0.23710152 |
| 159 | Salmonella infection_Homo sapiens_hsa05132 | 0.23483787 |
| 160 | Amoebiasis_Homo sapiens_hsa05146 | 0.23015378 |
| 161 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.21813798 |
| 162 | Renin secretion_Homo sapiens_hsa04924 | 0.21769600 |
| 163 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.19435688 |
| 164 | Asthma_Homo sapiens_hsa05310 | 0.19398110 |
| 165 | Phagosome_Homo sapiens_hsa04145 | 0.19223550 |
| 166 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.18926256 |
| 167 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.18872053 |
| 168 | Insulin secretion_Homo sapiens_hsa04911 | 0.18835898 |
| 169 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.18813276 |

